CeraVe - 0187-2200-01 - (Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide)

Alphabetical Index


Drug Information of CeraVe

Product NDC: 0187-2200
Proprietary Name: CeraVe
Non Proprietary Name: Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide
Active Ingredient(s): 4.95; 4.95; 4.95; 2.48; 23.41    g/99g; g/99g; g/99g; g/99g; g/99g & nbsp;   Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide
Administration Route(s): TOPICAL
Dosage Form(s): LOTION
Coding System: National Drug Codes(NDC)

Labeler Information of CeraVe

Product NDC: 0187-2200
Labeler Name: Valeant Pharmaceuticals North America LLC
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20120827

Package Information of CeraVe

Package NDC: 0187-2200-01
Package Description: 99 g in 1 TUBE (0187-2200-01)

NDC Information of CeraVe

NDC Code 0187-2200-01
Proprietary Name CeraVe
Package Description 99 g in 1 TUBE (0187-2200-01)
Product NDC 0187-2200
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide
Dosage Form Name LOTION
Route Name TOPICAL
Start Marketing Date 20120827
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Valeant Pharmaceuticals North America LLC
Substance Name HOMOSALATE; MERADIMATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Strength Number 4.95; 4.95; 4.95; 2.48; 23.41
Strength Unit g/99g; g/99g; g/99g; g/99g; g/99g
Pharmaceutical Classes

Complete Information of CeraVe


General Information